Results 41 to 50 of about 41,957 (164)

Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease

open access: yesFrontiers in Immunology, 2018
Acute graft-vs.-host disease (aGVHD) is a frequent complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), accounting for substantial morbidity and mortality associated with this treatment modality.
Nina C. Zitzer   +3 more
doaj   +1 more source

Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects

open access: yesOncoImmunology, 2017
The demethylating agent 5-azacytidine (AZA) has proven its efficacy in the treatment of myelodysplastic syndrome and acute myeloid leukemia. In addition, AZA can demethylate FOXP3 intron 1 (FOXP3i1) leading to the generation of regulatory T cells (Treg).
Grégory Ehx   +11 more
doaj   +1 more source

The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease

open access: yesFrontiers in Immunology, 2019
Allogeneic hematopoietic cell transplantation (allo-HCT) is performed with curative intent for high- risk blood cancers and bone marrow failure syndromes; yet the development of acute and chronic graft-vs.-host disease (GVHD) remain preeminent causes of ...
David Bastian   +4 more
doaj   +1 more source

Cytokine Detection and Modulation in Acute Graft vs. Host Disease in Mice

open access: yesMediators of Inflammation, 1994
A murine model for acute lethal graft vs. host disease (GVHD) was used to study the role that a number of cytokines play in the development of lethal GVHD. In this study we focused on the role of IL-1, IL-2, IL-4, IL-6, IFN-γ and TNF-α.
A. C. Knulst   +6 more
doaj   +1 more source

Treatment of Severe Steroid-Refractory Acute-Graft-vs.-Host Disease With Mesenchymal Stem Cells–Single Center Experience

open access: yesFrontiers in Bioengineering and Biotechnology, 2018
The most effective treatment of steroid refractory acute graft vs. host disease (aGvHD) is not yet established and mesenchymal stem cells (MSC) appear to be a promising therapy for the condition. We report single center case series of three patients, who
Maja Česen Mazič   +4 more
doaj   +1 more source

Complement and CD4+ T cells drive context-specific corneal sensory neuropathy

open access: yeseLife, 2019
Whether complement dysregulation directly contributes to the pathogenesis of peripheral nervous system diseases, including sensory neuropathies, is unclear.
Derek J Royer   +7 more
doaj   +1 more source

Looking into nerve damage in the cornea

open access: yeseLife, 2019
Interactions between T helper cells and the complement system promote loss of sensory neurons in the eye.
Mihaela Gadjeva
doaj   +1 more source

Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells

open access: yesNature Communications, 2017
Graft-vs.-host disease is a complication of allogenic hematopoietic stem cell transplantation, and is associated with endothelial dysfunction. Here the authors show that activated protein C signals via PAR2/PAR3 to expand Treg cells, mitigating the ...
Satish Ranjan   +24 more
doaj   +1 more source

The influence of dental care associated with laser therapy on oral mucositis during allogeneic hematopoietic cell transplant: retrospective study [PDF]

open access: yesEinstein (São Paulo), 2011
Objective: To verify decrease in frequency and severity of oralmucositis in patients submitted to dental care and laser therapyduring allogeneic hematopoietic cell transplant.
Fernanda de Paula Eduardo   +6 more
doaj  

Home - About - Disclaimer - Privacy